N Bhatla
Overview
Explore the profile of N Bhatla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta Y, Goyal A, Kalaivani M, Singhal S, Bhatla N, Gupta N, et al.
Diabet Med
. 2020 Mar;
37(6):1058-1065.
PMID: 32112453
Aim: To evaluate the burden and association of cardiometabolic risk factors in the spouses of women with and without hyperglycaemia in pregnancy. Methods: Women with (n = 204) and without...
2.
Gupta Y, Kapoor D, Josyula L, Praveen D, Naheed A, Desai A, et al.
Diabet Med
. 2018 Oct;
36(2):243-251.
PMID: 30368898
Aim: This study aims to determine whether a resource- and culturally appropriate lifestyle intervention programme in South Asian countries, provided to women with gestational diabetes (GDM) after childbirth, will reduce...
3.
Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, et al.
Gynecol Oncol Rep
. 2018 Jun;
25:65-69.
PMID: 29928684
Eighty-five percent of the incidents and deaths from cervical cancer occur in low and middle income countries. In many of these countries, this is the most common cancer in women....
4.
Garland S, Pitisuttithum P, Ngan H, Cho C, Lee C, Chen C, et al.
J Infect Dis
. 2018 May;
218(1):95-108.
PMID: 29767739
Background: A 9-valent human papillomavirus-6/11/16/18/31/33/45/52/58 (9vHPV) vaccine extends coverage to 5 next most common oncogenic types (31/33/45/52/58) in cervical cancer versus quadrivalent HPV (qHPV) vaccine. We describe efficacy, immunogenicity, and...
5.
Garland S, Giuliano A, Brotherton J, Moscicki A, Stanley M, Kaufmann A, et al.
Papillomavirus Res
. 2018 Mar;
5:87-88.
PMID: 29499389
No abstract available.
6.
Garland S, Brotherton J, Moscicki A, Kaufmann A, Stanley M, Bhatla N, et al.
Papillomavirus Res
. 2017 Nov;
4:35-38.
PMID: 29179867
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people...
7.
Gupta Y, Kapoor D, Desai A, Praveen D, Joshi R, Rozati R, et al.
Diabet Med
. 2016 Mar;
34(1):37-43.
PMID: 26926329
Aim: To investigate the distribution of and risk factors for dysglycaemia (Type 2 diabetes and prediabetes) in women with previous gestational diabetes mellitus in India. Methods: All women (n =...
8.
Prat J, Belhadj H, Berek J, Bermudez A, Bhatla N, Cain J, et al.
Eur J Gynaecol Oncol
. 2015 Sep;
36(4):367-9.
PMID: 26390684
No abstract available.
9.
Agarwal N, Gupta M, Kriplani A, Bhatla N, Singh N
J Obstet Gynaecol
. 2015 Jul;
36(1):71-5.
PMID: 26204126
The aim of this study was to compare combined hormonal vaginal ring with ultralow-dose combined oral contraceptive (COC) pills in management of heavy menstrual bleeding (HMB). Fifty patients were randomised...
10.
Garland S, Park S, Ngan H, Frazer I, Tay E, Chen C, et al.
Vaccine
. 2008 Aug;
26(43):5435-40.
PMID: 18706952
Asia accounts for more than half of all cases of cervical cancer registered globally and improving prevention is urgently needed. A range of tools and strategies is now available to...